Stock Updates

Is Novo Nordisk A/S(NYSE: NVO), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Novo Nordisk A/S (NYSE: NVO) has been on the stock market since its IPO date on the 01/04/1982. Novo Nordisk A/S is in the Drug Manufacturers – Other industry and Healthcare sector. Average volume for Novo Nordisk A/S, is 1347.82, and so far today it has a volume of 896800. Performance year to date since the 01/04/1982 is -3.00%.

To help you determine whether Novo Nordisk A/S is undervalued the following values will help you decide. P/E is 27.72 and forward P/E is 22.47. PEG perhaps more useful shows that Novo Nordisk A/S has a value for PEG of 2.37. P/S ratio is 6.82 and the P/B ratio is 25.39. The P/Cash and P/Free cash flow is 84.7 and 40.14 respectively.

At the current price Novo Nordisk A/S is trading at, 55.36 (1.47% today), Novo Nordisk A/S has a dividend yield of 1.73%, and this is covered by a payout ratio of 47.50%. Earnings per share (EPS) is 2, and this is looking to grow in the next year to 8.40% after growing 34.30% this past year. EPS growth quarter over quarter is -2.20%, and 8.00% for sales growth quarter over quarter.

The number of shares outstanding is 2013.06, and the number of shares float is 1356.68. The senior management bring insider ownership to 26.40%, and institutional ownership is at 10.30%. The float short is 0.18%, with the short ratio at a value of 1.8. Management has seen a return on assets of 40.40%, and also a return on investment of 85.00%.

The ability for Novo Nordisk A/S, to deal with debt, means it current ratio is 1.1, and quick ratio is 0.8. Long term debt/equity is 0 and total debt/equity is 0.01. In terms of margins, Novo Nordisk A/S has a gross margin of 84.90%, with its operating margin at 43.60%, and Novo Nordisk A/S has a profit margin of 31.30%.

The 52 week high is -6.63%, with 22.03% being its 52 week low. The 20 day simple moving average is 1.95% and the 200 day simple moving average is 2.49%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment